Furthermore, CSF2 has been shown to exert antitumor activity in gastrointestinal tract cancers, such as esophageal cancer (EC; 13), colorectal cancer (CRC) (14), and gastric cancer (GC; 15). Here, CSF2 is linked to colorectal cancer.